Medindia LOGIN REGISTER
Medindia
Advertisement

Risks for Kidney Disease Patients Increased by Poor Kidney Response to Hormone

by Kathy Jones on March 24, 2013 at 5:36 PM
 Risks for Kidney Disease Patients Increased by Poor Kidney Response to Hormone

A new study says that the kidneys response to a particular hormone may affect kidney disease patients heart health and longevity.

The study appears in an upcoming issue of the Journal of the American Society of Nephrology (JASN). The findings may help doctors as they monitor and treat patients with kidney disease.

Advertisement

In patients with chronic kidney disease (CKD), blood levels of a hormone called fibroblast growth factor-23 (FGF-23) rise in parallel with declining kidney function, causing excess excretion of phosphorus in the urine. Also, FGF-23 has been consistently and strongly linked with heart disease and premature death, but the mechanisms behind these links are unclear.

Julie Dominguez, MD, Joachim Ix, MD (University of California San Diego, and Veterans Affairs San Diego Healthcare System) and their colleagues wondered whether the kidneys response to the hormonal actions of FGF-23 may play a role. To investigate, they measured blood levels of FGF-23 and urine levels of phosphorus in 872 patients with CKD and cardiovascular disease.
Advertisement

Among the major findings:
- During an average 7.5 years of follow-up, there were 337 deaths and 199 cardiovascular events, such as heart attacks and strokes.
- Urinary phosphorus excretion significantly modified FGF-23's links with premature death and heart disease. Patients who had above-average FGF-23 but below-average urinary phosphorus had the highest risks of both premature death and cardiovascular events.

The findings reveal that associations of FGF-23 with premature death and cardiovascular events are stronger in people with lower urinary phosphorus independent of kidney function. In these individuals, the kidney's response to FGF-23 may be suboptimal.

"The relative resistance to the hormonal actions of FGF-23 in the kidney may identify novel aspects of kidney dysfunction, which may hold prognostic information for adverse health," said Dr. Ix. "Future studies are needed to determine the mechanisms of relative kidney resistance, and to determine their prognostic implications for other outcomes such as progression of kidney disease."

In an accompanying editorial, Ishir Bhan, MD, and Ravi Thadhani, MD (Massachusetts General Hospital) noted that the study prompts new questions to guide future studies into FGF-23 biology. "Perhaps the most important role of this study is to begin to shed some light on potential underlying mechanisms that might be at play in the complex relationship of FGF-23 and clinical effects, but many more questions are raised that this study is unable to answer," they wrote.

Study co-authors include Michael Shlipak, MD and Mary Whooley, MD.

Disclosures: The authors reported no financial disclosures.

The article, entitled "Fractional Excretion of Phosphorus Modifies the Association Between FGF23 and Outcomes," will appear online at jasn.asnjournals.org on March 21, 2013, doi: 10.1681/2012090894.

The editorial, entitled "Fibroblast Growth Factor-23 and Outcomes: New Answers, New Questions," will appear online at /jasn.asnjournals.org/ on March 21, 2013, doi: 10.1681/ASN.2013020169.

The content of this article does not reflect the views or opinions of The American Society of Nephrology (ASN). Responsibility for the information and views expressed therein lies entirely with the author(s). ASN does not offer medical advice. All content in ASN publications is for informational purposes only, and is not intended to cover all possible uses, directions, precautions, drug interactions, or adverse effects. This content should not be used during a medical emergency or for the diagnosis or treatment of any medical condition. Please consult your doctor or other qualified health care provider if you have any questions about a medical condition, or before taking any drug, changing your diet or commencing or discontinuing any course of treatment. Do not ignore or delay obtaining professional medical advice because of information accessed through ASN. Call 911 or your doctor for all medical emergencies.

Founded in 1966, and with more than 13,500 members, the American Society of Nephrology (ASN) leads the fight against kidney disease by educating health professionals, sharing new knowledge, advancing research, and advocating the highest quality care for patients.



Source: Newswise
Font : A-A+

Advertisement

Advertisement
Advertisement

Recommended Readings

Latest Research News

Exploring How Hearing Impairment Shapes Dementia Risk
Study reveals a correlation between hearing impairment and distinct brain region variances, contributing to dementia.
Coffee and its Role in Neurodegenerative Disorders
Financial impact of caring for individuals with neurodegenerative disorders reaches hundreds of billions annually in the United States.
Healthcare Industry Struggles With Tech Skills Shortage
Experts emphasize that addressing the skills gap demands immediate attention and innovative solutions, including education, re-training, and significant time investment.
Nano-Probes Uncover Cellular Reactions to Pressure
New study unveiled the cells' ability to adapt in responses and potential implications for conditions such as diabetes and cancer.
Brain Cells to Taste Buds Monitor Mindful Eating
Brainstem recording of tastebud neurons reveals the process of overindulgence of food, opening new avenues for weight loss drugs.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
×

Risks for Kidney Disease Patients Increased by Poor Kidney Response to Hormone Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests